Yiyi Wang
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 18, 2025
Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.Yiyi Wang, Jingya Gao, Furong Li
|Jan 31, 2024
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.Xiwen Zhang, Yue Xiao, Xiaohong Li
|Aug 11, 2022
Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study.Gaojie Li, Yuanxia Gu, Qin Zou
|May 26, 2022
The Tuberculosis Positive Conversion Rate Among Psoriasis Patients Treated with Adalimumab and Secukinumab: A Single-Center Retrospective Study in China.Yue Xiao, Hui Chen, Qin Zou
|Dec 20, 2021
Development of a Predictive Model for Screening Patients with Psoriasis at Increased Risk of Psoriatic Arthritis.Yiyi Wang, Lingyan Zhang, Min Yang
Pageof 1